Addex Therapeutics Ltd
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Addex Therapeutics Ltd generated cash of -$7,992,411, which is more than the previous year. Cash used in financing activities reached the amount of $5,264,596 last year. Net change in cash is therefore -$3,091,605.
Cash Flow
| 2014 | -1.79M | 373.45K | 472.64K |
|---|---|---|---|
| 2015 | -2.62M | 399.90K | 2.92M |
| 2016 | -2.69M | -1.51K | 1.49M |
| 2017 | -2.13M | -697 | 3.35M |
| 2018 | 1.75M | -61.74K | 37.39M |
| 2019 | -9.48M | -43.25K | -463.69K |
| 2020 | -12.18M | -59.41K | 46.39K |
| 2021 | -14.70M | -30.31K | 16.40M |
| 2022 | -16.43M | 2.97K | 3.10M |
| 2023 | -7.99M | -6.84K | 5.26M |
ADXN.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.95M | 20.48M | 18.69M | 31.53M | 41.67M | 2.57M | 1.41M | 2.63M | 1.97M | 2.91M |
Operating activities | ||||||||||
Net income | -10.55M | -20.80M | -15.35M | -12.85M | -14.78M | -1.64M | -3.28M | -3.14M | -4.20M | -1.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 305.95K | 323.14K | 347.61K | 378.75K | 333.84K | 2.93K | 15.24K | 25.76K | 25.87K | 110.13K |
Stock-based compensation expense | 0 | 3.68M | 1.17M | 1.17M | 1.68M | 2.29M | 800.18K | 197.34K | 355.90K | 275.74K |
| Deferred income tax benefit | 0 | 3.68M | 1.17M | 1.17M | 1.68M | 2.29M | 800.18K | 197.34K | 355.90K | 275.74K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 447.04K | -252.09K | -96.41K | 49.65K | 154.98K | 0 | -83.15K | 0 | 0 | 0 |
Inventories | 0 | 427.38K | -883.83K | 1.53M | -2.12M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -613.20K | -427.38K | 883.83K | -1.58M | 1.96M | 0 | -212.13K | 0 | 0 | 0 |
Cash generated by operating activities | -7.99M | -16.43M | -14.70M | -12.18M | -9.48M | 1.75M | -2.13M | -2.69M | -2.62M | -1.79M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -14.79K | -52.69K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -6.84K | -581 | -31.54K | -59.41K | -28.45K | -9.05K | -697 | -11.22K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 360.04K | 0 |
Cash generated by investing activities | -6.84K | 2.97K | -30.31K | -59.41K | -43.25K | -61.74K | -697 | -1.51K | 399.90K | 373.45K |
Financing activities | ||||||||||
Common Stock Issued | 2.35M | 1.67M | 13.95M | 720.01K | 5.98K | 40.48M | 3.38M | 1.52M | 3.18M | 468.32K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -48.05K | 0 | -390.18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -281.79K | -288.07K | -309.61K | -367.41K | -316.79K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.26M | 3.10M | 16.40M | 46.39K | -463.69K | 37.39M | 3.35M | 1.49M | 2.92M | 472.64K |
Net Change In Cash | -3.09M | -13.52M | 1.78M | -12.84M | -10.13M | 39.09M | 1.17M | -1.21M | 653.99K | -933.78K |
Cash at end of period | 3.86M | 6.95M | 20.48M | 18.69M | 31.53M | 41.67M | 2.59M | 1.41M | 2.63M | 1.97M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |